| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | MFT24BX55I |
Structure
| InChI Key | IEAKXXNRGSLYTQ-DEOSSOPVSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C27H28ClFN2OS |
| Molecular Weight | 483.05 |
| AlogP | 7.52 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 25.36 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 33.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family B G protein-coupled receptor
Peptide receptor (family B GPCR)
Corticotropin releasing factor receptor
Corticotropin releasing factor receptor
|
- | - | - | 240 | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Adrenal Hyperplasia, Congenital | 3 | D000312 | ClinicalTrials |
| Depressive Disorder | 2 | D003866 | ClinicalTrials |
Related Entries
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 34969 |
| ChEMBL | CHEMBL291657 |
| FDA SRS | MFT24BX55I |
| Guide to Pharmacology | 3533 |
| KEGG | C14129 |
| SureChEMBL | SCHEMBL5453205 |
| ZINC | ZINC000001550164 |
CONTENTS